Alendronate News
Merck signs deal for Fosamax authorized generic
Merck & Co Inc said on Friday it had signed a deal for an authorized generic form of its blockbuster Fosamax osteoporosis drug, to become available after the U.S. patent on the world's top-selling osteoporosis drug lapses on...
FDA Warns of Potential Side Effect of Bisphosphonate Use
Earlier this week, the FDA issued an alert highlighting the possibility of severe and sometimes incapacitating bone, joint and/or muscle pain in patients taking bisphosphonates. The agency is encouraging health care professionals...
FDA Provides Updated Information on Bisphosphonates
FDA is highlighting the possibility of severe and sometimes incapacitating bone, joint, and/or muscle (musculoskeletal) pain in patients taking bisphosphonates (marketed as Actonel, Actonel+Ca, Aredia, Boniva, Didronel, Fosamax,...
Forteo's Bone-building Power Shown In Arthritis Patients
The osteoporosis drug Forteo works better than Fosamax to strengthen bones in arthritis patients with prednisone-induced osteoporosis, according to a new study from a researcher at the University of Alabama at Birmingham (UAB.)
CROI: Alendronate effectively treats bone loss in men and women with HIV
Alendronate (Fosamax) is a safe and effective treatment for decreased bone mineral density in people with HIV, according to a study presented on Monday at the Fourteenth Conference on Retroviruses and Opportunistic Infections in...